Literature DB >> 1995050

Multifocal IOL implantation: 16 cases.

I Vanderschueren1, T Zeyen, B D'heer.   

Abstract

We interpreted the clinical data from 16 eyes with a 3M multifocal implant and compared them with data from 16 monofocal implants with the same follow-up period. The multifocal implant has several disadvantages: a lower initial visual acuity, a higher frequency of posterior synechiae, and slightly more difficult ophthalmoscopy than with conventional lenses. The great advantage of the multifocal implant is the good near visual acuity without additional correction.

Mesh:

Year:  1991        PMID: 1995050      PMCID: PMC504120          DOI: 10.1136/bjo.75.2.88

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  1 in total

1.  Contrast sensitivity in patients with a new type of multifocal intraocular lens.

Authors:  T Olsen; L Corydon
Journal:  J Cataract Refract Surg       Date:  1990-01       Impact factor: 3.351

  1 in total
  3 in total

1.  Consistent pattern in positional instability of polyfocal full-optics accommodative IOL.

Authors:  Yu Cheol Kim; Kyung Tae Kang; Youngdo Yeo; Ki-San Kim; Frank S Siringo
Journal:  Int Ophthalmol       Date:  2016-12-05       Impact factor: 2.031

2.  Evaluation of refractive correction for standard automated perimetry in eyes wearing multifocal contact lenses.

Authors:  Kazunori Hirasawa; Hikaru Ito; Yukari Ohori; Yui Takano; Nobuyuki Shoji
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

3.  Comparison of visual outcomes after bilateral implantation of a diffractive trifocal intraocular lens and blended implantation of an extended depth of focus intraocular lens with a diffractive bifocal intraocular lens.

Authors:  André Lins de Medeiros; André Gustavo de Araújo Rolim; Antonio Francisco Pimenta Motta; Bruna Vieira Ventura; César Vilar; Mário Augusto Pereira Dias Chaves; Pedro Carlos Carricondo; Wilson Takashi Hida
Journal:  Clin Ophthalmol       Date:  2017-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.